Mirosława Rulewicz-Warniełło

A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical study.

P. Kuna, M. Kupczyk, Michał Tarnowski, 2020, Respiratory medicine.